T1DAL ITN045AI: Inducing Remission in New Onset Type 1 Diabetes Mellitus with Alefacept(Amevive)
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://immport.org/shared/study/SDY797
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this trial is to test whether a drug called alefacept will slow or halt destruction of the beta cells in the pancreas. If the destruction of the beta cells is stopped, the patients might be able to produce insulin on their own longer, which could stop or slow the progression of their type 1 diabetes.
创建时间：
2025-10-30
